CHOI SLEDESKI YONG MI,GARDNER CHARLES J,LIANG GUYAN,POLI GREGORY B,SHUM PATRICK WAI KWOK,STOKLOSA GREGORY T,ZHAO ZHICHENG
申请号：
IN1554/CHENP/2012
公开号：
IN2012CN01554A
申请日:
2012.02.20
申请国别(地区):
IN
年份:
2012
代理人:
摘要：
or a prodrug, pharmaceutically acceptable salt, or solvate of said compound. Furthermore, the present invention is directed to a pharmaceutical composition comprising a pharmaceutically effective amount of the compound of formula I, and a pharmaceutically acceptable carrier. Furthermore, the present invention is directed to the use of a compound of formula I as an inhibitor of tryptase, comprising introducing the compound into a composition comprising tryptase. In addition, the present invention is directed to the use of a compound of formula I for treating a patient suffering from, or subject to, a physiological condition in need of amelioration of an inhibitor of tryptase comprising administering to the patient a therapeutically effective amount of the compound of Claim 1. The present invention is directed also to the preparation of a compound of formula I.
